| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-31 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 18645025 | |
| miR-31 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | High | 18971180 | |
| miR-31 | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-31* | Doxorubicin (Adriamycin) | breast cancer | Resistant | High | 19412672 | |
| miR-3183 | Doxorubicin (Adriamycin) | hepatocellular cancer | Sensitive | High | 23229111 | |
| miR-3117 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-3186 | Doxorubicin (Adriamycin) | hepatocellular cancer | Resistant | High | 23359607 | |
| miR-31 | Doxorubicin (Adriamycin) | breast cancer | Sensitive | Low | 23364795 | |
| miR-31 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-3131 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-3149 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-3162 | Doxorubicin (Adriamycin) | gastric cancer | Sensitive | High | 23525256 | |
| miR-3117 | Doxorubicin (Adriamycin) | chronic myelogenous leukemia | Resistant | High | 24303078 | |
| miR-31 | Doxorubicin (Adriamycin) | breast cancer | Resistant | Low | 25451164 |